Campbell & CO Investment Adviser LLC Takes $1.61 Million Position in Molina Healthcare, Inc $MOH

Key Points

• Campbell & CO Investment Adviser LLC has acquired a new stake in Molina Healthcare, purchasing 4,897 shares valued at approximately $1.6 million.
• Several institutional investors have also increased their holdings in Molina Healthcare, with Jump Financial LLC boosting its stake by 186.5% during the same period.
• Molina Healthcare's stock has experienced a decrease in price target ratings from multiple brokerages, including a notable cut from $373.00 to $179.00 by Robert W. Baird, indicating a shift in market outlook.

Campbell & CO Investment Adviser LLC bought a new position in Molina Healthcare, Inc (NYSE:MOH - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The firm bought 4,897 shares of the company's stock, valued at approximately $1,613,000.

A number of other institutional investors also recently bought and sold shares of MOH. Price T Rowe Associates Inc. MD raised its holdings in Molina Healthcare by 46.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company's stock worth $1,264,214,000 after purchasing an additional 1,216,903 shares during the period. GAMMA Investing LLC increased its stake in Molina Healthcare by 74,593.7% in the 1st quarter. GAMMA Investing LLC now owns 667,015 shares of the company's stock worth $219,708,000 after buying an additional 666,122 shares in the last quarter. Voloridge Investment Management LLC increased its stake in Molina Healthcare by 1,641.3% in the 4th quarter. Voloridge Investment Management LLC now owns 409,807 shares of the company's stock worth $119,274,000 after buying an additional 386,273 shares in the last quarter. Two Sigma Investments LP bought a new stake in Molina Healthcare during the fourth quarter valued at about $44,099,000. Finally, Nuveen LLC purchased a new position in shares of Molina Healthcare in the first quarter valued at about $46,441,000. 98.50% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on MOH shares. JPMorgan Chase & Co. cut their target price on Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating for the company in a research report on Tuesday, July 29th. Mizuho decreased their target price on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating on the stock in a research note on Friday, July 11th. Morgan Stanley downgraded Molina Healthcare from an "overweight" rating to an "equal weight" rating and decreased their target price for the company from $364.00 to $266.00 in a research note on Thursday, July 10th. Wall Street Zen downgraded Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Finally, Cantor Fitzgerald reissued a "neutral" rating and set a $210.00 target price on shares of Molina Healthcare in a research note on Tuesday, August 26th. Three research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $242.91.

Molina Healthcare Price Performance

NYSE:MOH traded up $6.15 during trading hours on Friday, reaching $180.87. The stock had a trading volume of 1,489,455 shares, compared to its average volume of 1,498,875. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. Molina Healthcare, Inc has a 52 week low of $151.95 and a 52 week high of $365.23. The company has a 50 day moving average price of $199.34 and a two-hundred day moving average price of $273.25. The stock has a market capitalization of $9.80 billion, a PE ratio of 8.91 and a beta of 0.54.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The firm had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. During the same period in the previous year, the firm earned $5.86 EPS. The business's revenue was up 15.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, COO James Woys acquired 10,000 shares of Molina Healthcare stock in a transaction on Monday, August 4th. The shares were acquired at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the purchase, the chief operating officer directly owned 74,331 shares in the company, valued at $11,591,176.14. The trade was a 15.54% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Ronna Romney sold 700 shares of the business's stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the transaction, the director directly owned 17,131 shares in the company, valued at approximately $2,633,719.94. This represents a 3.93% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.26% of the company's stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.